Archives: Speakers

Eleni Tokali, MPharm, MPH, is a Drug Intelligence Analyst at GlobalData. Her primary responsibilities include managing and maintaining GlobalData’s Drugs Database, analyzing drug pipeline information and producing analytical market insight reports. Additionally, Eleni provides timely client support and performs database quality checks. Prior to joining GlobalData, Eleni worked as a registered pharmacist under the General Pharmaceutical Council (GPhC). Eleni has a firm knowledge of pharmaceutical industry dynamics as well as global public health perspectives. Eleni holds a Master of Pharmacy from the University of Brighton and a Master of Public Health from King’s College London.

Hassan Naseri leads R&D in Next Generation Computing for Accenture Innovation. He manages projects in quantum computing, high-performance computing, scientific modelling and simulations, and networking. Hassan joined Accenture in 2018,  where his first role was leading an AI team that delivered innovative project in computer vision, network optimization, and AI-based automation. Prior to Accenture, Hassan worked as a scientist in academia, building novel algorithms for sensor networks and mobile devices using AI, optimization, and simulation techniques. He received his Ph.D. in Signal Processing Technology in 2018.

​​As a medical doctor specializing in cancer research, Daniel helps design innovative and lasting cancer treatments by translating Turbine’s computational findings into clinical insights. His primary responsibility is to understand complex scientific and medical challenges, guiding biologists, translational scientists, and data scientists in generating new discoveries that drive more effective treatments to patients.
 

​Daniel holds a PhD and has extensive experience in systems biology. His years at Turbine have deepened his expertise in building accurate models of complex biological processes, such as the payload response of ADCs.​ 

Justus Harris is a designer, healthcare strategist, and artist with two decades of lived type 1 diabetes experience. His expertise lies at the intersection of data visualization and narratives, enabling him to communicate personal and public health insights effectively. His creations encompass the transformation of medical data into 3D-printed objects, augmented reality experiences, and intuitive 2D designs. Features include the Kennedy Center as a Citizen Artist Fellow, Stanford Medicine X as an ePatient Scholar, and TEDx as a speaker.

His clients range from data-driven health companies such as Teledoc (formerly Livongo), One Drop, and Medidata as a Patient Insights Board member.

As an advocate, Justus is committed to helping improve the lives of patients in the ongoing COVID pandemic, patients without access to affordable treatments, and LGBTQIA+ individuals in the EU and United States.

With over 15 years of experience in Clinical Data Management, Bao leads business strategy and vendor operations for Takeda’s Clinical Data Management, Clinical Data Engineering, and Clinical Data Standards groups, driving organizational growth, managing global FSP partnerships, and enhancing cross-functional collaboration. As a member of the 2024–2025 OCT Advisory Board, Bao brings expertise in clinical outsourcing, strategic vendor partnerships, and RFP process optimization, providing a fresh vision for the organization.

Beyond professional achievements, Bao is dedicated to fostering collaboration and investing in the local community. As a partner of The Town FC and a Silicon Valley angel investor, Bao champions ventures that advance sustainable growth, youth enrichment, and innovation in technology.’

Hannah Zara Hans, MPharm, PG Clin Dip, EMBA, is the Director for Immunology at GlobalData, London. Hannah has over 13 years of experience in pharma and the clinical setting. She has experience in medical and commercial strategy across a breadth of therapy areas for products at various stages of development. Before Joining GlobalData, Hannah spent nine years at GSK working across therapy areas including Respiratory, HIV, and Early Assets. Her pharma experience included working on launch, competitor, and external engagement strategies for Respiratory and Infectious Diseases. Most recently, Hannah completed a secondment within the commercial Early Asset Portfolio Strategy team at GSK. Additionally, Hannah worked as a Clinical Pharmacist for four years within the hospital setting and a Clinical Commissioning Group in Manchester. Hannah holds a Master of Pharmacy from the University of Kent, a Post-Graduate Clinical Diploma from the University of Bradford, and an Executive Master of Business Administration (EMBA) from London Business School.